Inactivation of prenyltransferase inhibitors by S-methylation catalyzed by the methyltransferases TMT1A (METTL7A) and TMT1B (METTL7B)
En palabras de los autores
The thiol methyltransferases TMT1A and TMT1B (formerly METTL7A and METTL7B) metabolize thiol-containing compounds, but their substrate range and effects on drug activity remain incompletely defined. Here, we investigated whether these enzymes methylate protein prenyltransferase inhibitors and alter cellular sensitivity to these compounds. Mass spectrometry identified several thiol-containing farnesyltransferase and geranylgeranyltransferase inhibitors as substrates of both enzymes, whereas other thiol-containing inhibitors showed no detectable methylation. In HT1080 fibrosarcoma cells, TMT1A or TMT1B overexpression conferred resistance to several geranylgeranyltransferase inhibitors and attenuated drug-induced cell-cycle arrest. Pharmacological inhibition of TMT1A with 2,3-Dichloro--methylbenzylamine (DCMB, LY-78335) reversed resistance and restored cell-cycle arrest in TMT1A-expressing cells. These findings expand the known substrate range of TMT1A and TMT1B and support TMT-dependent methylation as a mechanism that reduces the cellular activity of susceptible prenyltransferase inhibitors.
Apareció: martes, 17 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.